Catalyst Pharma files lawsuit against U.S. FDA on Jacobus Pharma drug approval
Catalyst Pharmaceuticals Inc said on Wednesday it has filed a lawsuit against the U.S. Food and Drug Administration, challenging the recent approval of Jacobus Pharmaceutical Co's drug, Ruzurgi, for a rare neuromuscular disease.
from Reuters: Health News https://reut.rs/2wQLu4G
http://bit.ly/2zwRqiM